Gsk Pulls Out Of $20 Billion Race For Pfizer Consumer Assets

LONDON (Reuters) - GlaxoSmithKline has withdrawn from the race to buy Pfizer's consumer healthcare business, the British company said on Friday, endangering an auction the U.S. drugmaker hoped would bring in as much as $20 billion.

Topics:  london reuters     glaxosmithkline   pfizer   british   u.s    billion   race   consumer   
BING NEWS:
  • Why Pfizer Stock Blasted More Than 6% Higher Today
    Pfizer also did well with oncology drugs such as Ibrance and Xtandi.
    05/1/2024 - 10:55 am | View Link
  • Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
    Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year over year, beating the consensus of $0.54. The company witnesses a significant decrease in Comirnaty and Paxlovid ...
    05/1/2024 - 3:38 am | View Link
  • GSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit
    COVID-19 vaccine revenues have fallen precipitously for both Pfizer-BioNTech and Moderna over the last two years. In 2023, Comirnaty brought in $11.2 billion in sales, a steep 70% decline from the ...
    04/25/2024 - 11:04 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News